Literature DB >> 16203125

Capillary blood gases in acute exacerbations of COPD.

Ross Murphy1, Sanjeet Thethy, Simon Raby, Jean Beckley, John Terrace, Christine Fiddler, Michelle Craig, Colin Robertson.   

Abstract

OBJECTIVES: To assess the correlation and agreement between measurements of PO(2), PCO(2), H(+) and HCO(3)(-) in arterial and capillary blood in patients with acute exacerbations of COPD. To assess the repeatability of capillary measurements.
DESIGN: Method comparison study.
SETTING: Accident and emergency department in a university teaching hospital. MAIN OUTCOME MEASURES: Measurements of PO(2), PCO(2), H(+) and HCO(3)(-) in one arterial and two capillary samples taken from consecutive patients with acute exacerbations of COPD.
RESULTS: The agreement between measurements of PCO(2), H(+) and HCO(3)(-) in arterial and capillary blood was good with mean differences of 0.087 kPa, 1.044 nmol/l and 0.513 mmol/l, respectively. The corresponding 95% limits of agreement were narrow. The agreement between measurements of PO(2) was poor with a mean difference of 1.256 kPa and wide 95% limits of agreement. There was good repeatability between capillary samples with mean differences of 0.094 kPa, 0.674 nmol/l and 0.028 mmol/l for measurements of PCO(2), H(+) and HCO(3) respectively and narrow coefficients of repeatability.
CONCLUSIONS: Capillary blood gas measurements provide an accurate assessment of PCO(2), H(+) and HCO(3)(-) and can be used to reliably measure the ventilatory status of patients. Combined with continuous pulse oximetry they can be used as an alternative to arterial blood gas measurements in patients with acute exacerbations of COPD.

Entities:  

Mesh:

Year:  2005        PMID: 16203125     DOI: 10.1016/j.rmed.2005.08.007

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

1.  Predicting arterial blood gas values from venous samples in patients with acute exacerbation chronic obstructive pulmonary disease using artificial neural network.

Authors:  Mohammad Reza Raoufy; Parivash Eftekhari; Shahriar Gharibzadeh; Mohammad Reza Masjedi
Journal:  J Med Syst       Date:  2009-11-04       Impact factor: 4.460

2.  Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: 'Swimming between the flags'.

Authors:  Richard Beasley; Jimmy Chien; James Douglas; Leonie Eastlake; Claude Farah; Gregory King; Rosemary Moore; Janine Pilcher; Michael Richards; Sheree Smith; Haydn Walters
Journal:  Respirology       Date:  2015-11       Impact factor: 6.424

3.  A Decision for Predicting Successful Extubation of Patients in Intensive Care Unit.

Authors:  Chang-Shu Tu; Chih-Hao Chang; Shu-Chin Chang; Chung-Shu Lee; Ching-Ter Chang
Journal:  Biomed Res Int       Date:  2018-01-04       Impact factor: 3.411

4.  Agreement between arterial and non-arterialised fingertip capillary blood gas and acid-base values.

Authors:  Heidi K Kongstad; Christian A H Rosendal; Bodil S Rasmussen; Ulla M Weinreich
Journal:  Eur Clin Respir J       Date:  2019-07-25

5.  Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: 'Swimming between the flags'.

Authors:  Adrian Barnett; Richard Beasley; Catherine Buchan; Jimmy Chien; Claude S Farah; Gregory King; Christine F McDonald; Belinda Miller; Maitri Munsif; Alex Psirides; Lynette Reid; Mary Roberts; Natasha Smallwood; Sheree Smith
Journal:  Respirology       Date:  2022-02-17       Impact factor: 6.175

6.  Stability of pH, Blood Gas Partial Pressure, Hemoglobin Oxygen Saturation Fraction, and Lactate Concentration.

Authors:  Ariadna Arbiol-Roca; Claudia Elizabeth Imperiali; Dolors Dot-Bach; José Valero-Politi; Macarena Dastis-Arias
Journal:  Ann Lab Med       Date:  2020-06-17       Impact factor: 3.464

7.  Agreement between Arterial and Capillary pH, pCO2, and Lactate in Patients in the Emergency Department.

Authors:  Vincent Collot; Stefano Malinverni; Jabir Haltout; Eric Schweitzer; Pierre Mols; Magali Bartiaux
Journal:  Emerg Med Int       Date:  2021-07-06       Impact factor: 1.112

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.